Growing up in Central Mexico, I was fascinated by the popular belief that the indigenous people used "Montezuma's revenge" (better known as traveler's diarrhea) as a way to retaliate against the conquerors that colonized Latin America. As I made the study of diarrheagenic Escherichia coli the central pillar of my scientific career, it was evident that the simplistic concept of a vendetta against foreigners was an urban legend. Instead, diarrheal disease results from a complex interplay between different categories (pathovars) of E. coli, the environment, and the host's immune response.
Coalition for E. coli Research (LACER) was formed in 2009. LACER is comprised of a diverse group of individuals dedicated to promoting and expanding E. coli research projects, with particular focus on training and supporting the next generation of Latin American researchers. This coalition represents a multidisciplinary group of bacteriologists, public health officials, epidemiologists, molecular biologists, veterinarians, physicians, and other health-related experts distributed across more than 60 research groups located in different Latin American countries, Canada, and the United States.
What is unique about LACER that makes it a successful collaborative group of researchers? First, there is no fee to become a member. The only requirement is a full commitment to collaborate with other groups, both nationally and internationally, in an effort to advance pathogenic E. coli research. Second, LACER does not have a complex leadership team; instead, members are frequently consulted and participate in the decision-making process of all activities planned. Third, LACER members are devoted to improving the quality of education by sharing resources and allowing other groups to have access to equipment, reagents, and protocols that they might not have in their own laboratory. Finally, members can communicate their research findings through various symposiums, colloquiums, mini-courses, and social media outlets coordinated by LACER. Additionally, members are encouraged to increase the number and quality of their publications via an internal peer-review process.
Significant contributions have emerged from this international collaborative coalition, including five LACER symposiums, with more than 400 research posters presented by trainees since 2009. Importantly, the publication rate of E. coli research has been steadily increasing since the inception of LACER, with approximately 15% of the publications corresponding to collaborative research efforts between the LACER members. Additionally, by publishing two books, LACER continues to contribute to the education of the new generation of E. coli researchers. The most recent book, Escherichia coli in the Americas, covers basic concepts regarding different E. coli pathovars, including their environmental niche, virulence mechanisms, and host reservoir. This book also addresses disease outcomes, diagnosis, treatment, and vaccine development. However, perhaps the most important contribution of LACER has been the recent observation that "hybrid" E. coli pathovars (signature virulence factors from one pathovar found in another E. coli category) are currently emerging in Latin America and causing human disease. The potential of these strains to cause outbreaks has encouraged LACER members to become more vigilant and increase their exchange of information in order to detect and prevent the emergence of such strains.
As founder and current coordinator of LACER, my goal has been to facilitate interactions between groups of committed investigators in order to make the legends of "Montezuma's revenge," the "Aztec curse," the "Delhi belly," and "Gyppy tummy" a thing of the past. Through these effective collaborative research efforts, we can directly impact the well-being of these Latin American communities and the rest of the world.
